Teva Pharma (TEVA) call put ratio 52 calls to 1 put into quarter results
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $38.98 -0.54%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
EPS Growth %: -11.5%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
EPS Growth %: -11.5%
Join SI Premium – FREE
Teva Pharma (NYSE: TEVA) May weekly 14 straddle priced for a move of 7% into the expected release of quarter results before the bell on May 8.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Teva shares Phase 3 data on once-monthly schizophrenia injection
- Active options: TSLA NVDA MSTR AAPL SPCX GOOGL MU AMZN META
- XPeng Inc. (XPEV) call put ratio 2.7 calls to 1 put with a focus on October 14 calls
Create E-mail Alert Related Categories
Option EPS Action, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
